Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Carl Zeiss to Acquire Dutch Ophthalmic Research Center (D.O.R.C.) for ~€1B - Medical Product Outsourcing
Financial & Business, OEM News

Carl Zeiss to Acquire Dutch Ophthalmic Research Center (D.O.R.C.) for ~€1B

D.O.R.C. is a provider of retinal surgical devices.

Carl Zeiss Meditec began a deal to acquire 100% of the shares in Dutch Ophthalmic Research Center (D.O.R.C.) from Paris investment firm Eurazeo SE. The deal is valued at about €985 million and is expected to close in H1 2024.
 
D.O.R.C. is a provider of retinal surgical devices, enhancing and complementing Carl Zeiss’ ophthalmic portfolio and range of connected workflow solutions for eye conditions. D.O.R.C.’s portfolio of devices, disposables, and ophthalmic surgery liquids are poised to expand Zeiss’ position in vitreo-retinal (VR) surgery.
 
The EVA NEXUS platform is D.O.R.C.’s dual-function system and includes a range of accessories, instruments, and liquids for VR, cataract, and combined procedures.
 
“With the acquisition of Dutch Ophthalmic Research Center, we’ll bring together two highly innovative ophthalmic powerhouses to accelerate ZEISS’s position in the vitreo-retinal surgery segment and extend our leadership in the ophthalmic medical devices market,” said Dr. Markus Weber, president and CEO of Carl Zeiss.
 
“In the year when D.O.R.C. celebrates 40 years of innovation in ophthalmic surgery, we could not be more excited to join a market leader and visionary like ZEISS Medical Technology,” added Pierre Billardon, CEO of D.O.R.C. “We’ve built an amazing business with innovative, market-leading products and look forward to seizing this opportunity for growth and advancing the future of ophthalmic surgery. I am personally proud and immensely grateful to all of the team at D.O.R.C. for their commitment and expertise to help patients see again.”

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics